Trial Details

TERMINATED
Basic Information
Clinical ID c4002
Identifier NCT01199302
Trial Title Long-term Safety Study of Brodalumab in Adults With Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions BIOLOGICAL: Brodalumab
Participant Information
Sponsor Amgen
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-02-02
Primary Completion Date 2011-10-18
Completion Date 2011-10-18